{"date":"2026-04-21","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4178-2026-04-21-2203-441vkr","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-21","time":"22:03:22","subject":"公告本公司股票初次上市前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-21 22:03，「公告本公司股票初次上市前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2026-04-21-1934-1xpjlxk","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2026-04-21","time":"19:34:17","subject":"公告本公司115年第一季個別財務報告預計提報董事會日期","clause":"第31款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2026-04-21 19:34，「公告本公司115年第一季個別財務報告預計提報董事會日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-04-21-1839-13b5xld","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"18:39:10","subject":"公告本公司董事會決議分派現金股利","clause":"第31款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-04-21 18:39，「公告本公司董事會決議分派現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-04-21-1819-fl51x2","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-21","time":"18:19:33","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告召開2025年年度業績說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-21 18:19，「代重要子公司合富（中國）醫療科技股份有限公司公告召開2025年年度業績說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-04-21-1653-1r1w2m4","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"16:53:52","subject":"本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-04-21 16:53，「本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-04-21-1620-rf0iaj","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-04-21","time":"16:20:36","subject":"公告本公司董事會決議辦理114年度股東常會通過之第一次私募普通股定價及增資基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-04-21 16:20，「公告本公司董事會決議辦理114年度股東常會通過之第一次私募普通股定價及增資基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-04-21-1619-18h7x4u","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-04-21","time":"16:19:10","subject":"取消115年4月15日董事會通過私募普通股定價案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-04-21 16:19，「取消115年4月15日董事會通過私募普通股定價案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-04-21-1606-1nxb0oo","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-04-21","time":"16:06:48","subject":"因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-04-21 16:06，「因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2026-04-21-1546-qbjy0g","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"15:46:15","subject":"本公司受邀參加凱基證券與IR Trust共同舉辦之「2026逆齡產業新賽道研討會」","clause":"第30款","fact_date":"2026-04-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2026-04-21 15:46，「本公司受邀參加凱基證券與IR Trust共同舉辦之「2026逆齡產業新賽道研討會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-04-21-1533-bwopfv","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"15:33:00","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-04-21 15:33，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-04-21-1520-1uhskx3","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"15:20:23","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-04-21 15:20，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-04-21-1515-1ljupkr","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"15:15:25","subject":"公告本公司董事會通過114年合併財報","clause":"第43款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-04-21 15:15，「公告本公司董事會通過114年合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-04-21-1512-1uhsgf8","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"15:12:38","subject":"諾亞克董事會決議召開115年股東常會公告(新增報告事項)","clause":"第32款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-04-21 15:12，「諾亞克董事會決議召開115年股東常會公告(新增報告事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-04-21-1509-1lvo949","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-04-21","time":"15:09:35","subject":"公告本公司115年第一季合併財務報告預計提報董事會日期","clause":"第31款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-04-21 15:09，「公告本公司115年第一季合併財務報告預計提報董事會日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-21-1501-18c797s","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"15:01:29","subject":"代重要子公司居禮股份有限公司公告董事會決議不分派股利","clause":"第31款","fact_date":"2026-04-21","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-21 15:01，「代重要子公司居禮股份有限公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-04-21-0706-16qcz5v","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"07:06:56","subject":"本公司與GEM Yield Bahamas Limited簽署集團投資合作備忘錄，擬引進最高新台幣12.5億元投資額支持本公司新藥研發及營運發展。","clause":"第8款","fact_date":"2026-04-20","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-04-21 07:06，「本公司與GEM Yield Bahamas Limited簽署集團投資合作備忘錄，擬引進最高新台幣12.5億元投資額支持」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-04-21-0029-93furo","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-21","time":"00:29:03","subject":"公告本公司董事會通過2026年(115年)股東常會召開相關事宜(新增議案)","clause":"第32款","fact_date":"2026-04-20","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-04-21 00:29，「公告本公司董事會通過2026年(115年)股東常會召開相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}